Seegene USA Inc. has received FDA Emergency Use Authorization for the Allplex HSV1-1&2/VZV2/MPXV3 Assay, a multiplex ...

Countable Labs announces Ancora assays for molecular testing of hematologic malignancy, marking the company's entry into clinical markets.

EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...

Demand is shifting to rapid, decentralized and at-home molecular testing, creating opportunities in consumables, multiplex panels, portable PCR, CRISPR diagnostics and Asia-Pacific expansion.Dublin, ...

Co-Diagnostics has filed a Dual 510(k) premarket notification with the US Food and Drug Administration (FDA) for its Co-Dx PCR Flu A/B & RSV upper respiratory multiplex test, run on the Co-Dx PCR Pro ...

Many people will have experienced being unwell with an unknown infection and having to undergo multiple tests to determine the culprit. This sequential process of elimination can be time-consuming and ...

The two companies plan to establish a dedicated sales and distribution infrastructure ...

Detailed price information for Co-Diagnostics Inc (CODX-Q) from The Globe and Mail including charting and trades.

As restaurants, dairies and food manufacturers prepare for a surge in festive demand, rapid real-time PCR testing is emerging ...

The molecular diagnostics market size is valued at USD 17.6 billion in 2025 and is projected to reach USD 36.2 billion by the end of 2035, with a compound annual growth rate (CAGR) of 7.4% during the ...

New research shows a blood test can detect returning breast cancer months to years before scans or symptoms appear.